CBD Global Sciencesの収益
CBD Global Sciencesの収益は何ですか。
CBD Global Sciences Inc.の収益は703.855k$です。
収益の定義は何ですか。
収入とは、企業が通常の事業活動から得た収入であり、通常は商品やサービスの顧客への売却による収入です。
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
OTCのセクタHealth Careにおける収益の企業と比べるCBD Global Sciences
CBD Global Sciencesは何をしますか。
CBD Global Sciences Inc. engages in cannabidiol (CBD) farming, processing, and product manufacturing business. It offers provides biomass, CBD oil, and CBD oil products under the Aethics, CannaOil, and Strasburg Pharms brand names. The company was incorporated in 2018 and is headquartered in Lakewood, Colorado.
CBD Global Sciencesと類似の収益
- Elsightの収益は685.708k$です。
- CruzSurの収益は690.000k$です。
- Generex Biotechnologyの収益は692.762k$です。
- Tayo Rollsの収益は700.000k₨です。
- Hexagon Materialsの収益は703.000kAUD$です。
- EastWest Bioscienceの収益は703.102kCAD$です。
- CBD Global Sciencesの収益は703.855k$です。
- Sabre Resourcesの収益は704.000kAUD$です。
- DXIの収益は710.000kCAD$です。
- Sequana Medical NVの収益は712.000k€です。
- Strata-Xの収益は716.000kAUD$です。
- Strata-Xの収益は716.000kAUD$です。
- Realの収益は716.000kAUD$です。